These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4861252)

  • 1. The use of young mouse vagina as a model for experimental shigellosis.
    Kashiba S; Imanishi T; Miyama A; Yamade S; Yamada S
    Biken J; 1967 Mar; 10(1):25-32. PubMed ID: 4861252
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to experimental mouse shigellosis.
    Rauss K; Kétyi I
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):491-6. PubMed ID: 5666686
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of "intracellular parasitism" in experimental Shigella cystitis.
    Tenner C; Rácz P; Serény B
    Acta Microbiol Acad Sci Hung; 1971; 18(3):179-89. PubMed ID: 4949073
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intravaginal administration of Shigella in young mice].
    Kashiba S
    Kansenshogaku Zasshi; 1971 Jul; 45(7):295-9. PubMed ID: 5000006
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 6. Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development.
    Sansonetti P; Phalipon A
    Res Immunol; 1996; 147(8-9):595-602. PubMed ID: 9127893
    [No Abstract]   [Full Text] [Related]  

  • 7. Shigellosis in cynomolgus monkeys (Macaca irus). VII. Experimental production of dysentery with a relatively small dose of Shigella flexneri 2a in ascorbic acid deficient monkeys.
    Honjo S; Takasaka M; Fujiwara T; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1969 Jun; 22(3):149-62. PubMed ID: 4981384
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological studies on shigellosis by the mouse model technique. I. Antiinfective immunity of actively immunized mice.
    Rauss K; K0etyi I
    Acta Microbiol Acad Sci Hung; 1965-1966; 12(4):377-86. PubMed ID: 5871033
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological studies on shigellosis by the mouse model technique. I. Antiinfective immunity of actively immunized mice.
    Rauss K; Kétyi I
    Acta Microbiol Acad Sci Hung; 1965-1966; 12(4):377-86. PubMed ID: 5871082
    [No Abstract]   [Full Text] [Related]  

  • 10. Shigellosis in cynomolgus monkeys (Macaca irus). V. Resistance acquired by the repetition of experimental oral infection with Shigella flexneri 2A and fluctuation of serum agglutinin titer.
    Honjo S; Takasaka M; Fujiwara T; Kaneko M; Imaizumi K
    Jpn J Med Sci Biol; 1967 Aug; 20(4):341-8. PubMed ID: 4966140
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of dysentery bacteriophage on the course of experimental cystitis produced in guinea-pigs by Shigella flexneri.
    Manolov DG; Kosturkov GB
    J Hyg Epidemiol Microbiol Immunol; 1965; 9(4):455-9. PubMed ID: 5893861
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced isolation of Shigella species by extended incubation of primary isolation plates.
    Alam K; Hossain MA; Islam N; Sen SK; Sur GC; Talukder KA; Nair GB; Sack DA
    J Health Popul Nutr; 2003 Dec; 21(4):396-7. PubMed ID: 15038595
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental model of dysentery.
    Galikeyev KL; Shevchenko TF
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):37-43. PubMed ID: 6806355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriological and epidemiological approach to prophylaxy for enteric infection. IV. Experimental bladder infection of Shigella.
    Anzai H; Kubota Y; Okamoto M; Sekizuka S; Nakamura T
    Kitasato Arch Exp Med; 1971 Dec; 44(3):155-66. PubMed ID: 4949632
    [No Abstract]   [Full Text] [Related]  

  • 15. The nature of the lethal factor of Shigella flexneri.
    Jankowski S; Lachowicz TM
    Arch Immunol Ther Exp (Warsz); 1971; 19(1):47-66. PubMed ID: 4927483
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucosal lymphoid infiltrate dominates colonic pathological changes in murine experimental shigellosis.
    Martino MC; Rossi G; Martini I; Tattoli I; Chiavolini D; Phalipon A; Sansonetti PJ; Bernardini ML
    J Infect Dis; 2005 Jul; 192(1):136-48. PubMed ID: 15942903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous infection of virulent shigellae causes fulminant hepatitis in mice.
    Martino MC; Rossi G; Tattoli I; Martini I; Chiavolini D; Cortese G; Pozzi G; Bernardini ML
    Cell Microbiol; 2005 Jan; 7(1):115-27. PubMed ID: 15617528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Shigellosis abroad].
    Okolov IN; Brodianskiĭ IuM
    Tr Inst Im Pastera; 1983; 61():123-32. PubMed ID: 6379992
    [No Abstract]   [Full Text] [Related]  

  • 19. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental model of keratoconjunctival infections in the study of immunity against Shigella].
    Cefalù M; Puglisi C
    G Mal Infett Parassit; 1972 Apr; 24(4):281-9. PubMed ID: 5050309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.